The page below is a sample from the LabCE course Hemolytic Disease of the Fetus and Newborn. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Hemolytic Disease of the Fetus and Newborn (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 94 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart

International RhIg Policies

Currently, policies in the USA and UK favor giving RhIg to women who type as weak D.

In Canada, the Society of Obstetrics and Gyneacology recommends not giving RhIg to women who type as weak D BUT in some locations, weak D women do indeed receive RhIg in pregnancy.

Many other countries also recommend not giving RhIg to women who type as weak D but policies again vary even within countries.

Summary: Because policies vary internationally and change over time AND because the availability of molecular testing to differentiate weak and partial D Rh types will evolve, recommending a specific protocol for RhIg administration and weak D status is difficult.

Consult SOPs and policies in your transfusion services manual for the situation in your locale.